Adaptive Biotechnologies Ownership & Insider Activity

Adaptive Biotechnologies (ADPT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$6.5M total

Net Activity

Net Selling

Net Value (90d)

-$6.5M

Adaptive Biotechnologies Insider Transactions (Last 6 Months)

Voir toutes les transactions d'initiés →

Date	Insider	Title	Type	Shares	Price	Value
Oct 19, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL-OPTIONS	—	$18.40	$446K
Oct 14, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL-OPTIONS	—	$18.66	$465K
Oct 9, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL-OPTIONS	—	$18.97	$487K
Oct 6, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL-OPTIONS	—	$19.37	$516K
Oct 6, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	6.444K	$30.00	$193K
Oct 1, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL-OPTIONS	—	$20.30	$582K
Oct 1, 2026	Francis Lo	CHIEF PEOPLE OFFICER	SELL-OPTIONS	—	$17.53	$576K
Sep 16, 2026	Francis Lo	CHIEF PEOPLE OFFICER	SELL	9.846K	$18.82	$2.2M
Sep 15, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	1.195K	$27.00	$32K
Aug 26, 2026	Katey Einterz Owen	DIRECTOR	SELL	9.615K	$26.00	$250K
Aug 18, 2026	Robert Hershberg	DIRECTOR	SELL	15.664K	$15.36	$653K
Aug 17, 2026	Chad M Robins	CEO AND CHAIRMAN	SELL-OPTIONS	—	$15.68	$11.0M
Aug 17, 2026	Peter M Neupert	DIRECTOR	SELL	109.690K	$15.73	$3.0M
Aug 10, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	3.000K	$25.00	$75K
Jul 30, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	1.299K	$24.00	$31K
Jul 21, 2026	Harlan S Robins	CHIEF SCIENTIFIC OFFICER	SELL	207.600K	$14.22	$8.9M
Jul 16, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	5.000K	$23.00	$115K
Jul 15, 2026	Francis Lo	CHIEF PEOPLE OFFICER	SELL-OPTIONS	—	$15.75	$1.4M
Jul 2, 2026	Harlan S Robins	CHIEF SCIENTIFIC OFFICER	SELL	386.240K	$22.01	$8.5M
Jul 1, 2026	Francis Lo	CHIEF PEOPLE OFFICER	SELL	20.221K	$15.63	$1.5M
Jul 1, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	487.000	$22.00	$11K
Jun 26, 2026	Sharon Benzeno	CHIEF COMMERCIAL OFC IMM MED	SELL	51.473K	$14.44	$2.6M
Jun 25, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	5.000K	$20.50	$103K
Jun 25, 2026	Michelle Renee Griffin	DIRECTOR	SELL-OPTIONS	—	$13.99	$645K
Jun 15, 2026	Harlan S Robins	CHIEF SCIENTIFIC OFFICER	SELL	106.160K	$17.41	$1.8M
Jun 11, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	5.000K	$19.00	$95K
Jun 4, 2026	Francis Lo	CHIEF PEOPLE OFFICER	SELL	20.220K	$13.17	$522K
Jun 4, 2026	Susan Bobulsky	CHIEF COMMERCIAL OFFICER, MRD	SELL	11.000K	$18.00	$198K
May 18, 2026	Kyle Piskel	CHIEF FINANCIAL OFFICER	SELL	3.115K	$13.04	$41K
Apr 27, 2026	Julie Rubinstein	PRESIDENT AND COO	SELL	4.330K	$11.35	$146K

Adaptive Biotechnologies Corp

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Adaptive Biotechnologies Ownership & Insider Activity

Adaptive Biotechnologies Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch